Hivid®
Company
Roche Laboratories, Inc.
Use
Used in combination with antiretroviral agents for the treatment of HIV infection
Features
Third antiretroviral approved by FDA for HIV/AIDS
NIH Contribution
Didieoxycytidine (ddC) as inhibitor of HIV reverse-transcriptase
Approval Type
FDA
HHS Institute/Agency
NCI
Inventor(s)
H. Mitsuya
Year
1992
Tech Cat
Therapeutic
